• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fibroblast growth factor 21: from pharmacology to physiology.成纤维细胞生长因子 21:从药理学到生理学。
Am J Clin Nutr. 2010 Jan;91(1):254S-257S. doi: 10.3945/ajcn.2009.28449B. Epub 2009 Nov 11.
2
FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.成纤维细胞生长因子21在适应性饥饿反应过程中诱导过氧化物酶体增殖物激活受体γ共激活因子1α并调节碳水化合物和脂肪酸代谢。
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10853-8. doi: 10.1073/pnas.0904187106. Epub 2009 Jun 16.
3
Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.成纤维细胞生长因子21可增加肝脏过氧化物酶体增殖物激活受体γ共激活因子-1α缺陷小鼠的肝脏氧化能力,但不增加其体力活动或能量消耗。
Exp Physiol. 2018 Mar 1;103(3):408-418. doi: 10.1113/EP086629. Epub 2018 Jan 16.
4
[THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID METABOLISM].[成纤维细胞生长因子21(FGF21)在碳水化合物和脂质代谢调节与纠正中的作用]
Ross Fiziol Zh Im I M Sechenova. 2016 Dec;102(12):1406-16.
5
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.最近发现的代谢激素成纤维细胞生长因子 21 的生物学作用、临床意义和治疗可能性。
Eur J Endocrinol. 2012 Sep;167(3):301-9. doi: 10.1530/EJE-12-0357. Epub 2012 Jun 27.
6
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21.十二年的探索:成纤维细胞生长因子 21 的生理学和药理学研究进展
Cell Metab. 2019 Feb 5;29(2):246-253. doi: 10.1016/j.cmet.2019.01.004.
7
Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo.体内成纤维细胞生长因子 21(FGF21)对肝脏代谢的综合调节。
Endocrinology. 2011 Aug;152(8):2996-3004. doi: 10.1210/en.2011-0281. Epub 2011 Jun 28.
8
Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.肝 SIRT1 通过诱导成纤维细胞生长因子 21 减轻小鼠肝脂肪变性并控制能量平衡。
Gastroenterology. 2014 Feb;146(2):539-49.e7. doi: 10.1053/j.gastro.2013.10.059. Epub 2013 Nov 1.
9
Metabolic actions of fibroblast growth factor 21.成纤维细胞生长因子 21 的代谢作用。
Curr Opin Pediatr. 2012 Aug;24(4):523-9. doi: 10.1097/MOP.0b013e3283557d22.
10
Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.肝酰基辅酶 A 去饱和酶 1 缺乏症通过 PGC-1α-FGF21 轴部分增加脂肪组织中的葡萄糖摄取。
J Biol Chem. 2019 Dec 20;294(51):19475-19485. doi: 10.1074/jbc.RA119.009868. Epub 2019 Nov 5.

引用本文的文献

1
Protective Effects of Regular Physical Activity: Differential Expression of , and Their Receptors in Trained and Untrained Individuals.规律体育活动的保护作用:训练有素者与未训练者体内 、 及其受体的差异表达
Int J Mol Sci. 2025 Jul 23;26(15):7115. doi: 10.3390/ijms26157115.
2
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.健康与疾病中的巨噬细胞信号通路:从实验室到临床应用
MedComm (2020). 2025 Jun 16;6(7):e70256. doi: 10.1002/mco2.70256. eCollection 2025 Jul.
3
Not Just an Alternative Energy Source: Diverse Biological Functions of Ketone Bodies and Relevance of HMGCS2 to Health and Disease.不仅仅是一种替代能源:酮体的多种生物学功能以及HMGCS2与健康和疾病的相关性
Biomolecules. 2025 Apr 14;15(4):580. doi: 10.3390/biom15040580.
4
The Possible Role of Metformin and Fibroblast Growth Factor-21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together.二甲双胍和成纤维细胞生长因子-21在多发性硬化神经病理学中的可能作用:物以类聚。
Eur J Neurosci. 2025 Apr;61(7):e70067. doi: 10.1111/ejn.70067.
5
FGF2 Mediated USP42-PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration.成纤维细胞生长因子2介导的泛素特异性蛋白酶42-过氧化物酶体增殖物激活受体γ轴激活减轻肝脏氧化损伤并促进肝脏再生。
Adv Sci (Weinh). 2025 May;12(18):e2408724. doi: 10.1002/advs.202408724. Epub 2025 Mar 17.
6
Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery.解密非诺贝特在阿尔茨海默病和2型糖尿病中可能的机制作用:真相与谜团
J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.
7
The Impact of Human Liver Transplantation on the Concentration of Fibroblast Growth Factors: FGF19 and FGF21.人类肝脏移植对成纤维细胞生长因子浓度的影响:FGF19和FGF21
Int J Mol Sci. 2025 Feb 3;26(3):1299. doi: 10.3390/ijms26031299.
8
The role of FGF21 in the interplay between obesity and non-alcoholic fatty liver disease: a narrative review.成纤维细胞生长因子 21 在肥胖与非酒精性脂肪性肝病相互作用中的作用:一篇叙述性综述。
Rom J Morphol Embryol. 2024 Apr-Jun;65(2):159-172. doi: 10.47162/RJME.65.2.02.
9
Regulation of Keap1-Nrf2 signaling in health and diseases.Keap1-Nrf2信号通路在健康与疾病中的调控
Mol Biol Rep. 2024 Jul 13;51(1):809. doi: 10.1007/s11033-024-09771-4.
10
Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form.总的血清成纤维细胞生长因子 21 水平与内脏肥胖呈正相关,与其功能完整形式不同。
Front Endocrinol (Lausanne). 2023 Jun 20;14:1159127. doi: 10.3389/fendo.2023.1159127. eCollection 2023.

本文引用的文献

1
From bench to bedside: novel mechanisms and therapeutic advances through the development of selective peroxisome proliferator-activated receptor gamma modulators.从实验室到临床:通过开发选择性过氧化物酶体增殖物激活受体 γ 调节剂探索新的机制和治疗进展。
Am J Clin Nutr. 2010 Jan;91(1):251S-253S. doi: 10.3945/ajcn.2009.28449A. Epub 2009 Nov 18.
2
Peroxisome proliferator-activated receptor translational research and clinical experience.过氧化物酶体增殖物激活受体的转化研究和临床经验。
Am J Clin Nutr. 2010 Jan;91(1):262S-266S. doi: 10.3945/ajcn.2009.28449D. Epub 2009 Nov 18.
3
Adiponectin in insulin resistance: lessons from translational research.脂联素在胰岛素抵抗中的作用:转化研究的启示。
Am J Clin Nutr. 2010 Jan;91(1):258S-261S. doi: 10.3945/ajcn.2009.28449C. Epub 2009 Nov 11.
4
Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation.选择性过氧化物酶体增殖物激活受体 γ(PPARγ)调节作为一种更安全的治疗性 PPARγ 激活策略。
Am J Clin Nutr. 2010 Jan;91(1):267S-272S. doi: 10.3945/ajcn.2009.28449E. Epub 2009 Nov 11.
5
FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.成纤维细胞生长因子21在适应性饥饿反应过程中诱导过氧化物酶体增殖物激活受体γ共激活因子1α并调节碳水化合物和脂肪酸代谢。
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10853-8. doi: 10.1073/pnas.0904187106. Epub 2009 Jun 16.
6
Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.在中国受试者中,血清成纤维细胞生长因子21与不良血脂谱及γ-谷氨酰转移酶相关,但与胰岛素敏感性无关。
J Clin Endocrinol Metab. 2009 Jun;94(6):2151-6. doi: 10.1210/jc.2008-2331. Epub 2009 Mar 24.
7
The Klotho gene family as a regulator of endocrine fibroblast growth factors.作为内分泌成纤维细胞生长因子调节剂的Klotho基因家族。
Mol Cell Endocrinol. 2009 Feb 5;299(1):72-8. doi: 10.1016/j.mce.2008.10.052. Epub 2008 Nov 21.
8
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.成纤维细胞生长因子21可逆转饮食诱导的肥胖小鼠的肝脂肪变性,增加能量消耗,并改善胰岛素敏感性。
Diabetes. 2009 Jan;58(1):250-9. doi: 10.2337/db08-0392. Epub 2008 Oct 7.
9
Plasma FGF-21 levels in type 2 diabetic patients with ketosis.2型糖尿病酮症患者的血浆成纤维细胞生长因子21水平
Diabetes Res Clin Pract. 2008 Nov;82(2):209-13. doi: 10.1016/j.diabres.2008.07.012. Epub 2008 Aug 22.
10
Fibroblast growth factor 21 corrects obesity in mice.成纤维细胞生长因子21可纠正小鼠的肥胖问题。
Endocrinology. 2008 Dec;149(12):6018-27. doi: 10.1210/en.2008-0816. Epub 2008 Aug 7.

成纤维细胞生长因子 21:从药理学到生理学。

Fibroblast growth factor 21: from pharmacology to physiology.

机构信息

Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 73590-9041, USA.

出版信息

Am J Clin Nutr. 2010 Jan;91(1):254S-257S. doi: 10.3945/ajcn.2009.28449B. Epub 2009 Nov 11.

DOI:10.3945/ajcn.2009.28449B
PMID:19906798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2793111/
Abstract

Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family that functions as an endocrine hormone. Pharmacologic studies show that FGF21 has broad metabolic actions in obese rodents and primates that include enhancing insulin sensitivity, decreasing triglyceride concentrations, and causing weight loss. In lean rodents, FGF21 expression is strongly induced in liver by prolonged fasting through a mechanism that involves the nuclear receptor peroxisome proliferator-activated receptor alpha. FGF21, in turn, induces the transcriptional coactivator protein peroxisome proliferator-activated receptor gamma coactivator protein 1alpha and stimulates hepatic gluconeogenesis, fatty acid oxidation, and ketogenesis. FGF21 also blocks somatic growth and sensitizes mice to a hibernation-like state of torpor. Thus, FGF21 plays a key role in eliciting and coordinating the adaptive starvation response. Interestingly, FGF21 expression is induced in white adipose tissue by peroxisome proliferator-activated receptor gamma, which suggests that it also regulates metabolism in the fed state. This article highlights recent advances in our understanding of FGF21's pharmacologic and physiologic actions.

摘要

成纤维细胞生长因子 21(FGF21)是 FGF 家族中的一种非典型成员,作为一种内分泌激素发挥作用。药理研究表明,FGF21 在肥胖啮齿动物和灵长类动物中具有广泛的代谢作用,包括增强胰岛素敏感性、降低甘油三酯浓度和导致体重减轻。在瘦鼠中,FGF21 的表达通过涉及核受体过氧化物酶体增殖物激活受体α的机制,在长期禁食后在肝脏中被强烈诱导。反过来,FGF21 诱导转录共激活蛋白过氧化物酶体增殖物激活受体γ共激活蛋白 1α,并刺激肝糖异生、脂肪酸氧化和酮体生成。FGF21 还阻止躯体生长并使小鼠对类似于冬眠的状态敏感。因此,FGF21 在引发和协调适应性饥饿反应中起着关键作用。有趣的是,过氧化物酶体增殖物激活受体γ诱导白色脂肪组织中 FGF21 的表达,这表明它也调节进食状态下的代谢。本文重点介绍了我们对 FGF21 的药理和生理作用的理解的最新进展。